Advisor Group Holdings »

Cartesian Therapeutics shares owned by Advisor Group Holdings

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Advisor Group Holdings from 13F filings

Historical chart of Advisor Group Holdings investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by Advisor Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by Advisor Group Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.8k 234 16.12

More positions owned by Advisor Group Holdings

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Northern Lts Fd Tr Iv Main Sectr Rotn (SECT)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)

View all positions for Advisor Group Holdings

Top funds holding Cartesian Therapeutics

Siren
BlackRock
BlackRock
Citadel Advisors
Jpmorgan Chase & Co
MPM Oncology Impact Management
Vanguard Group
Dr. Jeffrey R. Jay, M.D.
Erste Asset Management GmbH
State Street Corporation
Geode Capital Management
Yale University
Logos Global Management
683 Capital Management
Northern Trust

View all funds holding Cartesian Therapeutics